Yangzhou Aurisco Pharmaceutical
China 1 employees Updated 9 July 2026
Yangzhou Aurisco Pharmaceutical is an API manufacturer based in China. It holds 18 active US drug master files and 2 valid CEPs across a filed portfolio of 16 molecules.
2
registered plants
1 with an FDA FEI number
1
filings
across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Sources: FDA Establishment Registration, read 4 May 2026.
Registered plants
| Site | FDA FEI |
| Yangzhou City, China | Not on file |
| China, China | 3021695089 |
What they file, and where
| Molecule | Regulators | Docs |
| Medroxyprogesterone Acetate | SFDA (Saudi Arabia), US FDA | 4 |
| Bempedoic Acid | SFDA (Saudi Arabia), US FDA | 3 |
| Brivaracetam | EDQM, US FDA | 3 |
| Semaglutide | US FDA | 2 |
| Clascoterone | US FDA | 1 |
| Dydrogesterone | EDQM | 1 |
| Elagolix | US FDA | 1 |
| Estetrol | US FDA | 1 |
| Estradiol | US FDA | 1 |
| Inclisiran | US FDA | 1 |
Show all 16 molecules on file
| Nusinersen | US FDA | 1 |
| Rimegepant | US FDA | 1 |
| Tenofovir Disoproxil | US FDA | 1 |
| Tirzepatide | US FDA | 1 |
| Vibegron | US FDA | 1 |
| Vutrisiran | US FDA | 1 |
Also appears on these molecule pages
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| JFDA (JO) | 1 | None |
Comparing suppliers?
Choose your molecules and target markets. Yangzhou Aurisco Pharmaceutical comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability